Embryotech Laboratories Inc - Company Review
Embryotech Laboratories Inc - Company ReviewSummary
Embryotech Laboratories Inc (ELI), a subsidiary of Hamilton Thorne Ltd is a medical equipment company that provides reproductive health diagnostics solutions. The company's embryo and ova products include cryopreserved mouse embryo and fresh rodent embryo. It also offers hamster ova research for assisted reproduction techniques. ELI cryo products include frozen mouse embryos and hamster ova. The company provides toxicity testing services such as mouse embryo assay, limulus amebocyte lysate assay, human sperm survival assay and mouse IVF assay. It customizes mouse embryo assays are used in the evaluation of raw materials, complete culture media, culture media supplements and other disposable items. ELI is headquartered in Haverhill, Massachusetts, the US.
This comprehensive company report of Embryotech Laboratories Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.